慢性阻塞性肺疾患稳定期采用舒利迭治疗的临床疗效浅析  

Chronic Obstructive Pulmonary Disease in Stable Phase by Analysis of Clinical Curative Effect of Seretide in the Treatment

作　　者：于欣[1] 

机构地区：[1]辽宁省阜新市中心医院呼吸内科,辽宁阜新123000

出　　处：《航空航天医学杂志》2015年第12期1466-1467,共2页Journal of Aerospace medicine

摘　　要：目的通过实验研究患有慢性阻塞性肺疾的患者,在稳定期使用舒利迭进行治疗的实际疗效。方法收集2013年2月~2014年9月到门诊进行质询,经专科医生诊断确诊患有慢性阻塞性肺疾病的患者共96名作为研究对象。使用随机分组的方法,将其划平均分成实验组和对照组。对所有的患者均使用常规的治疗方法进行治疗。实验组使用基础治疗方法进行治疗的同时使用舒利迭进行治疗,一个疗程后观察试验结果并进行分析。结果经过实验发现,实验组患者的治疗效果明显好于对照组患者的治疗效果同时两组患者均没有明显的不良反应。结论通过实验研究患有慢性阻塞性肺疾的患者,在稳定期使用舒利迭进行治疗的实际疗效,发现舒利迭可以有效治疗慢性阻塞性肺疾病,同时不良反应较少。Objective Through the experimental study with chronic obstructive pulmonary disease patients and in stable phase using Seretide treatment efficacy. Methods A total of 96 patients with chronic obstructive pulmonary disease who were diagnosed with chronic obstructive pulmonary disease were collected from February 2013 to September2014. Using the method of random grouping,it was divided into experimental group and control group. All patients were treated with conventional therapy. The experimental group using basic treatment method for treatment at the same time using Seretide treatment and after a course of treatment observation test results and analysis. Results After the experiment,the effect of the experimental group was significantly better than the control group,and there were no obvious adverse reactions in the two groups. Conclusions Through the experimental study with chronic obstructive pulmonary disease patients and in stable phase using Seretide treatment efficacy,Seretide is effective for the treatment of chronic obstructive pulmonary disease and less adverse reaction.

关 键 词：舒利迭 慢性阻塞性肺疾病 治疗效果 

分 类 号：R563[医药卫生—呼吸系统]